Reuters |
Amicus expects delay in filing for marketing rights for lead drug
Reuters Amicus Therapeutics said it was unlikely to submit a marketing application for its lead drug by the end of the year as expected, after the U.S. Food and Drug Administration asked the company better compile its trial data. The biotechnology company's ... Amicus says likely to delay marketing application for lead drug |
October 02, 2015 at 10:57AM | marketing - Google News
Amicus expects delay in filing for marketing rights for lead drug - Reuters
marketing - Google News
Nenhum comentário:
Postar um comentário